Hostname: page-component-7c8c6479df-hgkh8 Total loading time: 0 Render date: 2024-03-29T10:16:52.051Z Has data issue: false hasContentIssue false

Research and development for the National Health Service (Michael Peckham [1991]) Lancet, 338, 367–371

Published online by Cambridge University Press:  02 January 2018

Mark McCarthy*
Affiliation:
Bloomsbury and Islington and Hampstead Health Authorities 110 Hampstead Road, London NW1 2LJ
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Professor Michael Peckham's appointment as Director of Research and Development for the National Health Service in England reflects a new phase in central government's concern to influence health care research. Responding to the House of Lords' 1988 report Priorities in Medical Research, and to continuing doubts about the effectiveness of the Department of Health's own research management division, Professor Peckham's remit is to control all the research and development activities funded through the NHS - estimated at over £200 million.

Type
Expert opinions
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1991
Submit a response

eLetters

No eLetters have been published for this article.